```
json
{
"illness_name": "Prostate cancer",
"clinic": {
"name": "Sourasky Medical Center (Ichilov)",
"location": "Tel Aviv, Israel",
"accreditations": [
"JCI",
"Newsweek Top 10 for medical tourism"
],
"special_features": [
"Only da Vinci Xi in Israel/Middle East",
"Novalis TrueBeam STX radiotherapy",
"Multidisciplinary uro-oncology team",
"Free airport transfers",
"Russian-speaking coordinator"
],
"rating": 4.6
},
"doctor": {
"name": "Prof. David Sarid",
"title": "MD, Professor",
"specialization": "Clinical oncologist, Uro-oncology",
"experience_years": 37,
"procedures_performed": null,
"unique_qualifications": [
"Oxford-trained in prostate cancer",
"Chair of GU group, National Oncology Association",
"Chief of Prostate Oncology & Radiotherapy Department",
"30+ peer-reviewed publications"
]
},
"pricing": {
"currency": "USD",
"range": {
"min": 290,
"min_description": "Basic laboratory package",
"max": 32150,
"max_description": "Robotic radical prostatectomy with 5-day hospital stay"
},
"diagnostics": [
{
"name": "Laboratory package (CBC, biochemistry, PSA)",
"price_range": {
"low": 290,
"high": 380
}
},
{
"name": "MRI prostate",
"price": 2470
},
{
"name": "PET-CT PSMA (Ga-68)",
"price_range": {
"low": 2580,
"high": 2730
}
},
{
"name": "MRI-guided fusion biopsy",
"price": 3850
},
{
"name": "Oncologist consultation with Prof. Sarid",
"price": 950
},
{
"name": "Urologist consultation",
"price_range": {
"low": 700,
"high": 750
}
},
{
"name": "Biopsy material revision",
"price_range": {
"low": 650,
"high": 680
}
}
],
"treatments": [
{
"name": "Robotic radical prostatectomy (da Vinci Xi or Si)",
"price_range": {
"low": 25210,
"high": 32150
},
"includes": [
"Consumables and equipment",
"ECG",
"Anesthesiologist consultation",
"5-day surgical hospitalization",
"Airport transfers",
"Interpreter"
],
"not_included": [
"flights",
"hotel beyond hospital stay"
]
},
{
"name": "Brachytherapy (radioactive seed implant)",
"type": "internal radiation",
"technique": "HDR VARIAN BRAVOS system",
"key_benefit": "90% efficacy, no admission required",
"hospital_stay": "Day case",
"price": null
},
{
"name": "External beam radiotherapy",
"type": "high-precision radiotherapy",
"equipment": "Novalis TrueBeam STX",
"key_benefit": "spares healthy tissue",
"price": null
},
{
"name": "Lutetium-177 PSMA therapy",
"type": "theranostic radionuclide therapy",
"indication": "metastatic castration-resistant prostate cancer",
"prerequisite": "positive Ga-68 PSMA PET/CT",
"hospital_stay": null,
"key_benefit": "targets advanced disease",
"price": null
},
{
"name": "Xofigo (radium-223 dichloride)",
"type": "bone-targeted radiotherapy",
"indication": "bone-metastatic prostate cancer",
"key_benefit": "prolongs survival by ~10 years stage 4",
"price": null
}
]
},
"diagnostics_available": [
"Laboratory panel (CBC, chemistry, PSA, free PSA)",
"Prostate ultrasound (TRUS)",
"Prostate MRI",
"PET-CT PSMA",
"MRI ultrasound fusion biopsy",
"Second opinion histopathology review",
"BRCA1 / BRCA2 testing",
"MSI/mismatch-repair dMMR testing"
],
"treatments_available": [
{
"name": "Robot-assisted radical prostatectomy (da Vinci)",
"type": "minimally invasive surgery",
"equipment": "da Vinci Xi (4th generation)",
"hospital_stay": "5 days",
"key_benefit": "nerve-sparing option, faster recovery"
},
{
"name": "Brachytherapy",
"type": "internal radiation",
"technique": "radioactive seed implant (I-125)",
"hospital_stay": "day case",
"key_benefit": "targeted dose, preserves nearby tissue"
},
{
"name": "External-beam radiotherapy (Novalis)",
"type": "image-guided IMRT/VMAT",
"equipment": "Novalis TrueBeam STX",
"hospital_stay": "outpatient",
"key_benefit": "highly conformal, minimal side-effects"
},
{
"name": "HIFU",
"type": "non-invasive ultrasound ablation",
"key_benefit": "94-99 % 10-year survival early disease"
},
{
"name": "Lutetium-177 PSMA therapy",
"type": "peptide-receptor radionuclide therapy",
"indication": "metastatic castration-resistant",
"key_benefit": "for advanced resistant disease"
},
{
"name": "Xofigo (radium-223)",
"type": "bone-seeking alpha therapy",
"indication": "bone metastases",
"key_benefit": "survival extension"
}
],
"key_selling_points": [
"Price spectrum: basic diagnostics $290-$950, da Vinci prostatectomy $25-32k all-inclusive",
"Prof. David Sarid: Oxford-trained, 37 yrs experience, heads prostate oncology & radiotherapy depts",
"Only da Vinci Xi robotic system in Israel/Middle East, nerve-sparing surgery available",
"Cutting-edge imaging: Ga-68 PSMA PET-CT with 85-90 % accuracy vs 70 % choline",
"Global pioneer: offers Lutetium-177 PSMA therapy few centers worldwide provide"
]
}
```